Diet :: Diet pill for dogs may cure biscuit binge

Dogs are usually indulged in eating biscuits, and it causes obesity in them. Now dogs have slimming drug Slentrol, manufactured by Pfizer, to control obesity. The Food and Drug Administration (FDA) today is announcing the approval of Slentrol (dirlotapide), a prescription drug for the management of obesity in dogs.

Obesity :: FDA approves Pfizer’s Slentrol for obesity in dogs

The Food and Drug Administration (FDA) today is announcing the approval of Slentrol (dirlotapide), a prescription drug for the management of obesity in dogs. Slentrol reduces appetite and fat absorption to produce weight loss. A veterinarian will determine whether the dog should be treated, based on the dog’s weight and general health.

Osteoporosis :: Proposed FDA claim recognizes role of key nutrients in dairy in reducing osteoporosis risk

The Food and Drug Administration has proposed an amended health claim that would communicate to consumers the value of foods high in calcium and vitamin D for reducing the risk of osteoporosis. The National Dairy Council (NDC) acknowledges and supports the body of scientific evidence that backs the proposed claim, which indicates that a lifestyle that includes a well-balanced diet with adequate calcium and vitamin D, and physical activity, helps reduce the risk of osteoporosis.

Nanotech safety needs specific government risk research strategy and funding

“Prioritizing nanotechnology risk research isn’t rocket science,” said Project on Emerging Nanotechnologies chief scientist Andrew Maynard. Dr. Maynard’s remark is in his testimony today before the federal government’s first public meeting focused exclusively on research needs and priorities for the environmental, health and safety risks of engineered nanoscale materials.

In-shell vaccine for chick disease

Infectious bronchitis virus causes devastating losses to the poultry industry but scientists are now developing a new way to vaccinate chicks against the disease — one that can be delivered while they are still in their egg. Researchers have used a “reverse genetic” system to produce a new vaccine strain which is safe to deliver to chicks while they are still in the egg, making it more effective than current vaccines.

Cancer :: Study calculates patient time costs associated with cancer care

In 2005, the overall cost of patients’ time spent on cancer care was $2.3 billion in the first year after diagnosis, according to a new study in the Jan. 3 issue of the Journal of the National Cancer Institute. The time costs for the 11 cancers studied and for different phases of cancer care varied widely, they write.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack